WelcomeTo ALIF

The treatment landscape in acute leukemia continues to evolve rapidly. Advances in disease biology, molecular classification, targeted therapies, transplantation and measurable residual disease are reshaping how we understand the disease and how we make treatment decisions for our patients.

ALIF brings together hematologists, hemato-oncologists, transplant specialists, researchers and healthcare professionals to examine these developments through evidence-based discussion, expert perspectives and real-world clinical experience.

Our ambition is to create more than an annual scientific meeting. We aim to establish a forum where knowledge is shared openly, challenging questions are debated, international expertise connects with regional practice, and meaningful collaborations can develop.

I warmly invite our scientific community and industry partners to join us in Dubai as we work together toward a shared purpose: advancing acute leukemia care and improving outcomes for patients.